midazolam and gw 4064

midazolam has been researched along with gw 4064 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bass, JY; Caravella, JA; Chen, L; Creech, KL; Deaton, DN; Madauss, KP; Marr, HB; McFadyen, RB; Miller, AB; Mills, WY; Navas, F; Parks, DJ; Smalley, TL; Spearing, PK; Todd, D; Williams, SP; Wisely, GB1
Ding, X; Fang, C; Jia, K; Zhang, P; Zhang, QY; Zhou, X1

Other Studies

2 other study(ies) available for midazolam and gw 4064

ArticleYear
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Binding Sites; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Dogs; Fluorescence Resonance Energy Transfer; Humans; Isoxazoles; Ligands; Mice; Molecular Conformation; Naphthalenes; Protein Structure, Tertiary; Quinolines; Rats; Receptors, Cytoplasmic and Nuclear; Weight Gain

2011
Dietary regulation of mouse intestinal P450 expression and drug metabolism.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:2

    Topics: Animal Feed; Animals; Bile Acids and Salts; Biotransformation; Cytochrome P-450 Enzyme System; Diet; Female; Hydroxylation; Intestines; Isoenzymes; Isoxazoles; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes, Liver; Midazolam; NADPH-Ferrihemoprotein Reductase; Receptors, Cytoplasmic and Nuclear; Substrate Specificity

2013